The Pharmaceutical Inspection Co-operation Scheme (PIC/S) has warned inspectors that job cuts at manufacturing sites may lead to a shift in lower quality and even compliance issues later on. The PIC/S has also urged regulators to use job cuts as a factor in risk-based inspection plans. The PIC/S issued their concerns in a recommendation document sent to regulators on January 1, 2012.They assert that job cuts lead to fewer quality assurance resources available which may lead to poor quality and higher risk. To read the full PIC/S recommendation document, click here. To read the rest of the article, click here.
